SIMCERE PHARMA (02096) spent 10.1667 million Hong Kong dollars to repurchase 1.49 million shares on November 18th.
Sinopharm (02096) announced that on November 18, 2024, the company invested 1016.67 million...
SIMCERE PHARMA (02096) announced that on November 18, 2024, the company repurchased 1.49 million shares at a cost of 10.167 million Hong Kong dollars. The repurchase price was between 6.71 and 6.98 Hong Kong dollars per share.
Related Articles
EMPEROR INT'L (00163) plans to sell its properties in Macau.
ENVISION GREEN (01783) has issued 118 million shares under general authorization.
US Stock Market Move | SpaceX (SPCX.US) fell nearly 5% as restricted shares were unlocked again, putting pressure on the stock price.
EMPEROR INT'L (00163) plans to sell its properties in Macau.
ENVISION GREEN (01783) has issued 118 million shares under general authorization.
US Stock Market Move | SpaceX (SPCX.US) fell nearly 5% as restricted shares were unlocked again, putting pressure on the stock price.
RECOMMEND
